CDH1 and neoplasm: Two contradicting roles have been reported for the E-cadherin; the first is a predominant tumor-suppressing role to interfere with the pro-tumorigenic transformation that is promoted by β-catenin-activating mutations as well as a role in intracellular signaling that ultimately inhibits metastasis [125].